BlackRock Floating Rate Income Strategies Fund (FRA) and Eaton Vance Floating Rate Income Fund (EFT)...
Biotech ETF Trend Likely to Continue
08/15/2012 10:00 am EST
This high flyer shows no clear signs of stopping, although caution is always warranted, writes Frank Kollar.
Shares of the Market Vectors Biotech ETF (BBH) may have the reputation of being volatile, but for those looking for a strong current uptrend, BBH fits the bill.
Since hitting correction lows at $29.33 back on August 7, 2011, BBH has risen steadily over the past year to $49.66 as of Monday, August 13 near the close. This 69% gain puts the biotech sector near the top in performance.
There is still some volatility, and buyers of this ETF should be prepared for 5% to 8% pullbacks.
A trailing stop around 10% should protect against a further corrective movement. Even lower risk would be had with a stop at $47 a share, the July 24 correction low.
Frank Kollar can be found at FibTimer.com.
Related Articles on ETFs
iShares Russell 2000 (IWM) is an ETF that tracks the Russell 2000 Index (RUT). It is the most liquid...
O’Shares Global Internet Giants ETF (OGIG) is the newest addition to O’Shares’ gro...
The iShares MSCI Brazil ETF peaked on January 25 and has since declined 30.8%, officially entering c...